LumiraDx | Investor Presentation Deck | 32 slides

LumiraDx · 2023-03
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

5
coverage by narrative range · generated from this deck JSON

Slide inventory

32
every slide · same image gating as the playbook
01
Slide 1
Includes copyright footer and date.front_matter
03
This slide serves as a corporate update/disclosure regarding financial status and SEC filings.summarize
04
The slide uses a list-based structure to summarize key company pillars.summarize
05
The slide uses a process flow diagram to contrast the inefficiencies of central lab testing with the benefits of POC testing.frame_problem
Open slide detailBeat · ProblemLoop · Cost Of Inaction
06
The slide highlights both the individual team members and the pedigree of their past professional experience.other
Open slide detailBeat · TeamLoop · Cost Of Inaction
07
The slide uses a list of pain points on the left and illustrative examples of existing POC devices on the right.frame_problem
Open slide detailLoop · Cost Of Inaction
08
present_solution
Open slide detailBeat · SolutionLoop · Cost Of Inaction
09
compare_peers
Open slide detailLoop · Cost Of Inaction
10
present_solution
Open slide detailLoop · Cost Of Inaction
11
The chart compares price multiples relative to Central Lab pricing.compare_peers
Open slide detailLoop · Cost Of Inaction
12
The slide uses a numbered process flow (1-8) to explain the technical mechanism of the assay.present_solution
Open slide detailBeat · ProductLoop · Cost Of Inaction
13
The slide uses a color-coded border system to distinguish between test types (Qualitative Immunoassay, Quantitative Immunoassay, Enzyme, Molecular).present_solution
Open slide detailLoop · Cost Of Inaction
14
present_solution
Open slide detailLoop · Cost Of Inaction
15
present_solution
Open slide detailLoop · Cost Of Inaction
16
Includes a scatter plot showing method comparison between LumiraDx and bioMérieux Vidas.present_solution
Open slide detailLoop · Cost Of Inaction
17
The slide emphasizes the unique value proposition of a fingerstick test for heart failure diagnosis.present_solution
Open slide detailLoop · Cost Of Inaction
18
The table highlights LumiraDx's unique selling points in green text (Fingerstick capillary, specific menu items, Room temperature storage).compare_peers
Open slide detailLoop · Cost Of Inaction
19
The slide uses dashed blue boxes to highlight key differentiators for the 'True POC Needs' column.compare_peers
Open slide detailBeat · Market SizeLoop · Cost Of Inaction
20
The scatter plot shows a strong linear correlation (R^2 = 0.9868) between the two testing methods.show_traction
Open slide detailLoop · Cost Of Inaction
21
The slide uses a process diagram to show the workflow and a series of amplification curves alongside a comparative table to demonstrate performance.show_traction
Open slide detailLoop · Cost Of Inaction
22
The chart shows a 'TB Care Cascade' which is a common public health framework for tracking patient retention.show_traction
Open slide detailLoop · Cost Of Inaction
23
The workflow is depicted as a process diagram with a timeline at the bottom.present_solution
Open slide detailLoop · Cost Of Inaction
24
Uses a visual 'X' to denote legacy/fragmented systems being replaced.present_solution
Open slide detailLoop · Cost Of Inaction
25
The slide uses a stacked bar chart to show total customer growth and a dual-line chart to show the shift in customer behavior (COVID-only vs. multi-assay).show_traction
Open slide detailLoop · Cost Of Inaction
26
show_traction
Open slide detailLoop · Cost Of Inaction
27
The slide uses a hub-and-spoke diagram to show the central procurement of instruments and their distribution into four specific clinical use cases.illustrate_case
Open slide detailLoop · Cost Of Inaction
28
The slide uses a chronological list to show how diagnostic testing influenced clinical decision-making.illustrate_case
Open slide detailLoop · Cost Of Inaction
29
The slide uses a color-coded system to distinguish between different testing technologies (Qualitative Immunoassay, Quantitative Immunoassay, Molecular, Enzyme,present_solution
Open slide detailLoop · Cost Of Inaction
30
The slide features a product render of the LumiraDx platform and a row of 10 distinct test strip icons representing various diagnostic assays.appendix
31
The slide uses a two-column layout to contrast Western healthcare policy shifts with global health initiatives.establish_context
32
The slide contains only the company logo and a copyright notice.front_matter